Related Experiment Video

Updated: Jun 25, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

[Generalized tuberculous infection in infants]

F A Batyrov, O K Kiselevich, I V Shirshov

    Problemy Tuberkuleza I Boleznei Legkikh
    |March 4, 2009
    PubMed

    Insights

    Generalized tuberculosis in infants is a severe condition, with 10% developing it early and facing high mortality. Early, intensive, individualized treatment with higher drug doses is crucial for infant tuberculosis survival.

    Area of Science:

    • Pediatrics
    • Infectious Diseases
    • Public Health

    Background:

    • Tuberculosis (TB) in infants presents unique challenges due to the developing immune system.
    • Generalized forms of TB in infants are associated with significant morbidity and mortality.

    Observation:

    • Analysis of 10-year hospital records reveals that 10% of infant tuberculosis cases progress to generalized forms at an early age.
    • Early-onset generalized tuberculosis in infants carries a high fatality rate, with nearly all affected infants dying.

    Findings:

    • Generalized tuberculosis in infants necessitates a prolonged, intensive, and individualized treatment approach.
    • The administration of higher doses of antitubercular drugs is clinically justifiable in these severe cases.

    Implications:

    • Findings underscore the need for heightened vigilance and early intervention strategies for infant tuberculosis.
    • Optimized treatment protocols, including higher drug dosages, may improve outcomes for infants with generalized TB.
    • Further research into risk factors and preventative measures for generalized infant tuberculosis is warranted.

    More Related Videos

    Intradermal Inoculation of Mycobacterium avium in the Mouse Ear09:20

    Intradermal Inoculation of Mycobacterium avium in the Mouse Ear

    Published on: July 3, 2025

    Related Concept Videos

    Pulmonary Tuberculosis IV01:26

    Pulmonary Tuberculosis IV

    Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
    Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
    Pulmonary Tuberculosis I01:29

    Pulmonary Tuberculosis I

    Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
    Causative Organism
    The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
    Mode of...
    Pulmonary Tuberculosis II01:28

    Pulmonary Tuberculosis II

    Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
    Here is a detailed explanation of its pathophysiology:
    Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
    Tuberculosis01:23

    Tuberculosis

    Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
    Pulmonary Tuberculosis III01:31

    Pulmonary Tuberculosis III

    Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
    The first classification is based on the development of the disease, and it includes the following categories:
    Pulmonary Tuberculosis V01:28

    Pulmonary Tuberculosis V

    Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
    Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...